57939-04-5
57939-04-5 structure
- Name: 1-(1H-Pyrazol-1-yl)propan-2-amine
- Chemical Name: 1-(1H-Pyrazol-1-yl)-2-propanamine
- CAS Number: 57939-04-5
- Molecular Formula: C6H11N3
- Molecular Weight: 125.17200
- Create Date: 2019-01-01 19:52:23
- Modify Date: 2025-08-25 18:50:14
| Name | 1-(1H-Pyrazol-1-yl)-2-propanamine |
|---|---|
| Synonyms |
4-Methyl-3-nitro-benzoesaeure-methylester
3-nitro-4-phenoxy-5-sulphamylbenzoic acid methyl ester methyl 3-nitro-4-phenoxy-5-sulfamoylbenzoate Methyl 3-nitro-p-toluate Methyl 3-nitro-4-methylbenzoate 3-nitro-4-phenoxy-5-sulfamoylbenzoic acid methyl ester 4-Methyl-3-nitrobenzoic acid methyl ester |
| Molecular Formula | C6H11N3 |
|---|---|
| Molecular Weight | 125.17200 |
| Exact Mass | 125.09500 |
| PSA | 43.84000 |
| LogP | 0.93060 |
|
~%
57939-04-5 |
| Literature: NEUROTHERAPEUTICS PHARMA, INC.; WANASKI, Stephen; COLLINS, Stephen; KINCAID, John Patent: WO2012/18635 A2, 2012 ; Location in patent: Page/Page column 111 ; WO 2012/018635 A2 |
|
~96%
57939-04-5 |
| Literature: CONCERT PHARMACEUTICALS INC.; Tung, Roger Patent: US2014/128469 A1, 2014 ; Location in patent: Paragraph 0110; 0112 ; |
|
~%
57939-04-5 |
| Literature: NEUROTHERAPEUTICS PHARMA, INC.; WANASKI, Stephen; COLLINS, Stephen; KINCAID, John Patent: WO2012/18635 A2, 2012 ; WO 2012/018635 A2 |
|
~%
57939-04-5 |
| Literature: NEUROTHERAPEUTICS PHARMA, INC.; WANASKI, Stephen; COLLINS, Stephen; KINCAID, John Patent: WO2012/18635 A2, 2012 ; WO 2012/018635 A2 |
